SEC 13F Intelligence

Geneva Partners, LLC / ELV

Geneva Partners, LLC’s Elevance Health Inc Formerly Position

Does Geneva Partners, LLC own Elevance Health Inc Formerly (ELV)? Not currently — the last reported position was 5.3K shares worth $2M in Q1 2023; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$2M
Q1 2023
Shares
5.3K
% of Portfolio
+2.09%
Quarters Held
5
position exited

Position History ELV

Reported value by quarter
Q1 ’22: $6MQ1 ’22Q2 ’22: $5MQ2 ’22Q3 ’22: $5MQ3 ’22Q4 ’22: $5MQ4 ’22Q1 ’23: $2MQ1 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20235.3K$2M+2.09%
Q4 20229.8K$5M+4.74%
Q3 202210.2K$5M+5.27%
Q2 202210.7K$5M+5.06%
Q1 202211.8K$6M+3.60%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Geneva Partners, LLC’s full portfolio or all institutional holders of ELV.